At 10:30 IST, the barometer index, the S&P BSE Sensex, was down 171.85 points or 0.23% to 81,152.76. The Nifty 50 index shed 89.20 points or 0.36% to 24,711.65.
The Sensex and Nifty clocked an all-time high of 81,587.76 and 24,854.80, respectively in early trade.
The broader market underperformed the frontline indices, the S&P BSE Mid-Cap index declined 1.35% and the S&P BSE Small-Cap index fell 1.42%.
The market breadth was weak. On the BSE, 936 shares rose and 2,625 shares fell. A total of 142 shares were unchanged.
Earnings Today
Reliance Industries (down 1.06%), Wipro (down 0.86%), Aether Industries (up 1.52%), Atul (down 1.72%), Blue Dart Express (up 2.86%), Bharat Petroleum Corporation (down 3.24%), Creditaccess Grameen (down 1.01%), Oberoi Realty (down 3.25%), Jubilant Pharmova (down 1.99%), Patanjali Foods (up 2.58%), One97 Communication (up 4.17%), PVR Inox (down 0.16%), Route Mobile (up 1.41%), Supreme Petrochem (down 3.07%), Tejas Networks (down 0.02%), Transformers and Rectifiers (down 3.04%), UltraTech Cement (down 1.39%) and Union Bank of India (up 0.59%) will announce their quarterly results later in the day.
Buzzing Index:
The Nifty Metal index declined 2.14% to 9,431.10. The index fell 3.06% in three consecutive trading sessions.
National Aluminium Company (down 3.37%), NMDC (down 3.23%), Steel Authority of India (down 2.85%), Hindustan Copper (down 2.78%), Tata Steel (down 2.67%), Jindal Stainless (down 2.67%), Hindalco Industries (down 2.57%), Jindal Steel & Power (down 2.11%), Welspun Corp (down 1.98%) and JSW Steel (down 1.95%) advanced.
Stocks in Spotlight:
Vodafone Idea shed 0.92%. The telecom operators board approved the second tranche allotment of shares to Nokia Solutions and Networks India and Ericsson India aggregating to Rs 614.5 crores at an issue price of Rs 14.80 per share.
Dr. Reddy's Laboratories rose 0.43%. The company said that it has entered into a non-exclusive patent licensing agreement with Takeda Pharmaceutical Company to commercialise Vonoprazan tablets in India.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
